Adherence to oral treatments in elderly patients with advanced prostate cancer: The ADHERE study, a prospective trial of the Meet-URO network.

Journal of Clinical Oncology（2022）

引用 4|浏览7

暂无评分

摘要

Physicians tend to treat older mCRPC patients with ENZ. Non-adherence rate is relatively low overall but can be higher with ABI than with ENZ and correlates with the Geriatric G8 score. Forgetfulness is a potential barrier for ENZ.

查看译文

关键词

abiraterone,adherence,compliance,elderly,enzalutamide,frailty,patient-reported outcome,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要